Cytokines in Liver Injury and Repair

Inbunden, Engelska, 2002

1 698 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This book, the proceedings of Falk Symposium No. 125 on 'Cytokines in Liver Injury and Repair' (Progress in Gastroenterology and Hepatology Part II), held in Hannover, Germany, on September 30 - October 1, 2001, provides an update of our current knowledge on the role of cytokines in various human and experimental liver diseases and on their present and prospective use in therapeutic trials. The book contains chapters by most well-known experts in the field who have contributed significantly to our present knowledge on cytokines in liver injury and repair.

Produktinformation

Utgivningsdatum:2002-06-30
Mått:155 x 235 x 29 mm
Vikt:837 g
Format:Inbunden
Språk:Engelska
Serie:Falk Symposium
Antal sidor:400
Upplaga:2002
Förlag:Kluwer Academic Publishers
ISBN:9780792387756

Utforska kategorier

Hepatologi inom Medicin
Gastroenterologi inom Medicin

Innehållsförteckning

Preface. Section I: Cytokine-Induced Cell Death. 1. Endogenous modulators of receptor-mediated hepatic cell death; H. Hentze, et al. 2. Modulation of CD 95 (APO-1/Fas) induced hepatocyte death by NO; PR. Galle, et al. 3. TGF-beta-induced liver cell apoptosis; R. Schulte-Hermann, et al. Section II: Regulation of Normal and Malignant Cell Growth by Cytokines. 4. Proliferative and apoptotic effects of tumour necrosis factor in the liver and cells in culture; N. Fausto, J. Campbell. 5. The role of insulin-like growth factor-II in hepatocarcinogenesis; P. Lund, et al. 6. Transforming growth factor-beta and cancer; M. Reiss. 7. Cytokines and hepatitis C virus replication; D. Moradpour, et al. Section III: Cytokine Signals in Fibrogenesis. 8. Role of DDR2 receptor in the activation of hepatic stellate cells; E. Olaso, et al. 9. PDGF signalling in activated stellate cells; M. Pinzani. 10. Escape of activated hepatic stellate cells from TGF-beta control; S. Dooley, et al. 11. Chemokines in the modulation of liver inflammation; F. Marra, et al. Section IV: Modulation of Fibrogenic Cytokine Response. 12. Identification of fibrogenic genes in a polygenic mouse model of liver fibrosis; F. Lammert, et al. 13. Cytokine transgenic models of fibrogenesis; S. Kanzler. 14. The fibrogenic mediators of TGF-beta and TNF-alpha as surviving factors for activated hepatic stellate cells; G. Ramadori, B. Saile. 15. Resolution of fibrosis by apoptosis of myofibroblasts; F. Murphy, J.P. Iredale. Section V: Cytokines in the Cause and Consequence of Cholestatis. 16. Regulation of hepatic organic anion transporters by cytokines; A. Geier, et al. 17. Reaction of cholangiocytes to inflammatory injury; C. Spirli, et al. 18. Bid antisense oligodeoxynucleotides as therapy for cholestatic liver injury; H. Higuchi, G.J. Gores. Section VI: Polymorphisms of Cytokines and Signalling. 19. Regulation of interleukin-6-type cytokine signaling; P.C. Heinrich, et al. 20. IL6-dependent signal transduction and its relevance in animal models; K.L. Streetz, et al. 21. Predictive value of cytokine polymorphisms for liver disease; P.T. Donaldson, C.P. Day. Section VII: Therapeutic Cytokines and Modulators. 22. PPARgamma and fibrogenesis; T. Miyahara, et al. 23. Cytokine modulation in the therapy of hepatic immunopathology and fibrosis; S.M. Wahl, et al. 24. Matrix binding motifs and peptide mimetics as modulators of wound healing and fibrogenesis; D. Schuppan, et al. 25. Endothelin and liver injury -- therapeutic antagonism of the endothelin system; D.C. Rockey. 26. Transforming growth factor ss in the treatment of autoimmune disease; A.W. Lohse. Section VIII: Cytokine-Assisted Gene Therapies. 27. The feasibility of antifibrotic gene therapy; T.J. Davern, D.M. Bissell. 28. Experimental approaches to antifibrotic strategies using gene transfer; R. Weiskirchen, et al. 29. Cytokine-assisted gene therapy: Anti-TGF-ss intervention using mutated forms of TGF-ss receptor; H. Ueno, et al. 30. Cytokine-based gene therapy of hepatocellular carcinoma (HCC); C. Qian, et al. Index.

Mer från samma serie

Hepatobiliary Transport: From Bench to Bedside

S. Matern, J.L. Boyer, D. Keppler, P.J. Meier-Abt

Inbunden, 2001

1 698 kr

Acute and Chronic Liver Diseases

R. Schmid, L. Bianchi, H.E. Blum, W. Gerok, K.P. Maier, G.A. Stalder

Inbunden, 1996

2 262 kr

Molecular Diagnosis and Gene Therapy

H.E. Blum, C.H. Wu, G.Y. Wu

Inbunden, 1996

2 262 kr

Pregnancy, Sex Hormones and the Liver

H. B. Reyes, U. Leuschner, H.B. Reyes, U. Leuschner, I.M. Arias

Inbunden, 1996

2 262 kr

Glucocorticoid Therapy in Chronic Inflammatory Bowel Disease

H.W. Mollmann, B. May

Inbunden, 1996

1 698 kr

Cholestatic Liver Diseases in Children and Adults

C.E. Broelsch, M. Burdelski, X. Rogiers

Inbunden, 1997

1 135 kr

Zinc and Diseases of the Digestive Tract

J.D. Kruse-Jarres, J. Schölmerich

Inbunden, 1997

1 698 kr

Bile Acids and Hepatobiliary Diseases - Basic Research and Clinical Application

G. Paumgartner, A. Stiehl, W. Gerok

Inbunden, 1997

2 262 kr

Gut as a Model in Cell and Molecular Biology

F. Halter, D. Winton, N.A. Wright

Inbunden, 1997

2 849 kr

Constipation and Ano-Rectal Insufficiency

K. Ewe, V.F. Eckardt, P. Enck

Inbunden, 1997

2 262 kr

Du kanske också är intresserad av

10% rabatt på allt

Exit Adventskalender - Julens magi (SE)

Exit

499 kr

Clinical Research in Gastroenterology 1

S. Matern

Häftad, 2011

571 kr

Hepatobiliary Transport: From Bench to Bedside

S. Matern, J.L. Boyer, D. Keppler, P.J. Meier-Abt

Inbunden, 2001

1 698 kr

Hepatic Metabolism and Disposition of Endo- and Xenobiotics

Karl-Walter Bock, W. Gerok, S. Matern

Inbunden, 1991

2 262 kr

Clinical Research in Gastroenterology 2

S. Matern

Inbunden, 1989

1 135 kr

Clinical Research in Gastroenterology 1

S. Matern

E-bok

2012

732 kr

Clinical Research in Gastroenterology 2

S. Matern

E-bok

2012

1 455 kr

Clinical Research in Gastroenterology 2

S. Matern

Häftad, 2011

1 135 kr

Ruth Kvarnström-Jones - SIGNERAD - Systrarna på Sophiahemmet, Inbunden

Signerad!

Del 3

SIGNERAD - Systrarna på Sophiahemmet

Ruth Kvarnström-Jones

Inbunden, 2026

249 kr

Signerad!

SIGNERAD - Hälsorevolutionen : nya insikter

Yourlife Books

Inbunden, 2026

259 kr

Cytokines in Liver Injury and Repair

AvA. M. Gressner,P. C. Heinrich

Inbunden, Engelska, 2002

Del i serien Falk Symposium

1 698 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Produktinformation

Utgivningsdatum:2002-06-30
Mått:155 x 235 x 29 mm
Vikt:837 g
Format:Inbunden
Språk:Engelska
Serie:Falk Symposium
Antal sidor:400
Upplaga:2002
Förlag:Kluwer Academic Publishers
ISBN:9780792387756

Utforska kategorier

Hepatologi inom Medicin
Gastroenterologi inom Medicin

Innehållsförteckning

Preface. Section I: Cytokine-Induced Cell Death. 1. Endogenous modulators of receptor-mediated hepatic cell death; H. Hentze, et al. 2. Modulation of CD 95 (APO-1/Fas) induced hepatocyte death by NO; PR. Galle, et al. 3. TGF-beta-induced liver cell apoptosis; R. Schulte-Hermann, et al. Section II: Regulation of Normal and Malignant Cell Growth by Cytokines. 4. Proliferative and apoptotic effects of tumour necrosis factor in the liver and cells in culture; N. Fausto, J. Campbell. 5. The role of insulin-like growth factor-II in hepatocarcinogenesis; P. Lund, et al. 6. Transforming growth factor-beta and cancer; M. Reiss. 7. Cytokines and hepatitis C virus replication; D. Moradpour, et al. Section III: Cytokine Signals in Fibrogenesis. 8. Role of DDR2 receptor in the activation of hepatic stellate cells; E. Olaso, et al. 9. PDGF signalling in activated stellate cells; M. Pinzani. 10. Escape of activated hepatic stellate cells from TGF-beta control; S. Dooley, et al. 11. Chemokines in the modulation of liver inflammation; F. Marra, et al. Section IV: Modulation of Fibrogenic Cytokine Response. 12. Identification of fibrogenic genes in a polygenic mouse model of liver fibrosis; F. Lammert, et al. 13. Cytokine transgenic models of fibrogenesis; S. Kanzler. 14. The fibrogenic mediators of TGF-beta and TNF-alpha as surviving factors for activated hepatic stellate cells; G. Ramadori, B. Saile. 15. Resolution of fibrosis by apoptosis of myofibroblasts; F. Murphy, J.P. Iredale. Section V: Cytokines in the Cause and Consequence of Cholestatis. 16. Regulation of hepatic organic anion transporters by cytokines; A. Geier, et al. 17. Reaction of cholangiocytes to inflammatory injury; C. Spirli, et al. 18. Bid antisense oligodeoxynucleotides as therapy for cholestatic liver injury; H. Higuchi, G.J. Gores. Section VI: Polymorphisms of Cytokines and Signalling. 19. Regulation of interleukin-6-type cytokine signaling; P.C. Heinrich, et al. 20. IL6-dependent signal transduction and its relevance in animal models; K.L. Streetz, et al. 21. Predictive value of cytokine polymorphisms for liver disease; P.T. Donaldson, C.P. Day. Section VII: Therapeutic Cytokines and Modulators. 22. PPARgamma and fibrogenesis; T. Miyahara, et al. 23. Cytokine modulation in the therapy of hepatic immunopathology and fibrosis; S.M. Wahl, et al. 24. Matrix binding motifs and peptide mimetics as modulators of wound healing and fibrogenesis; D. Schuppan, et al. 25. Endothelin and liver injury -- therapeutic antagonism of the endothelin system; D.C. Rockey. 26. Transforming growth factor ss in the treatment of autoimmune disease; A.W. Lohse. Section VIII: Cytokine-Assisted Gene Therapies. 27. The feasibility of antifibrotic gene therapy; T.J. Davern, D.M. Bissell. 28. Experimental approaches to antifibrotic strategies using gene transfer; R. Weiskirchen, et al. 29. Cytokine-assisted gene therapy: Anti-TGF-ss intervention using mutated forms of TGF-ss receptor; H. Ueno, et al. 30. Cytokine-based gene therapy of hepatocellular carcinoma (HCC); C. Qian, et al. Index.